Boeing Eyes Cash Positive 2026 After Years of Financial Struggles
Boeing projects positive cash flow in 2026 after $2B burn in 2025. CFO outlines turnaround plan amid 777X delays and production recovery efforts.
NOTRELOAD AI
FDA Fast-Tracks New Treatment for Chronic Nerve Pain
Sangamo Therapeutics (SGMO) receives FDA Fast Track designation for ST-503, a promising non-opioid treatment for small fiber neuropathy causing chronic pain.
Bending Spoons to Acquire Eventbrite in $500M All-Cash Deal
Bending Spoons will acquire Eventbrite for $500 million, offering shareholders $4.50 per share. The deal aims to enhance Eventbrite with new features, AI tools, and improved event search, with closing expected in the first half of 2026.
Wedbush Names Unity a Top Pick with Higher $55 Price Target
Wedbush adds Unity to its "Best Ideas List", raises price target to $55, and highlights strong long-term growth potential driven by game engine leadership, mobile ads, and new payment solutions.
Jasper Therapeutics Stock Jumps on Positive Asthma Drug Results
Jasper Therapeutics (JSPR) shares rise 60% after experimental drug briquilimab shows promising results in early-stage asthma study, improving lung function and reducing inflammation.
Morgan Stanley Issues Key Rating Changes Across MedTech and Healthcare Stocks
Morgan Stanley updates ratings for Inspire Medical, DexCom, and Bausch + Lomb, highlighting slowing growth, improving operations, and strong long-term pipelines.